125 related articles for article (PubMed ID: 25537724)
1. Comparison of primary and secondary breast cancers in adolescents and young adults.
Sadler C; Goldfarb M
Cancer; 2015 Apr; 121(8):1295-302. PubMed ID: 25537724
[TBL] [Abstract][Full Text] [Related]
2. Comparison of secondary and primary thyroid cancer in adolescents and young adults.
Goldfarb M; Freyer DR
Cancer; 2014 Apr; 120(8):1155-61. PubMed ID: 24615715
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
[TBL] [Abstract][Full Text] [Related]
4. Age at Primary Malignancy Determines Survival in Adolescent and Young Adults That Develop a Secondary Thyroid Cancer.
Lau BJ; Goldfarb M
J Adolesc Young Adult Oncol; 2016 Jun; 5(2):201-8. PubMed ID: 27042962
[TBL] [Abstract][Full Text] [Related]
5. Cancer in adolescents and young adults (15-29 years): a population-based study in the Netherlands 1989-2009.
Aben KK; van Gaal C; van Gils NA; van der Graaf WT; Zielhuis GA
Acta Oncol; 2012 Sep; 51(7):922-33. PubMed ID: 22934554
[TBL] [Abstract][Full Text] [Related]
6. Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival.
Beinart G; Gonzalez-Angulo AM; Broglio K; Mejia J; Ruggeri A; Mininberg E; Hortobagyi GN; Valero V
Clin Breast Cancer; 2007 Dec; 7(11):867-74. PubMed ID: 18269777
[TBL] [Abstract][Full Text] [Related]
7. Colon cancer as a subsequent malignant neoplasm in young adults.
Teng A; Nelson DW; Dehal A; Chang SC; Fischer T; Steele SR; Goldfarb M
Cancer; 2019 Nov; 125(21):3749-3754. PubMed ID: 31290995
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort.
Teepen JC; Kremer LC; van der Heiden-van der Loo M; Tissing WJ; van der Pal HJ; van den Heuvel-Eibrink MM; Loonen JJ; Louwerens M; Versluys B; van Dulmen-den Broeder E; Visser O; Maduro JH; van Leeuwen FE; Ronckers CM;
Cancer Causes Control; 2019 Sep; 30(9):909-922. PubMed ID: 31300947
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
[TBL] [Abstract][Full Text] [Related]
10. Bilateral breast cancer, synchronous and metachronous; differences and outcome.
Jobsen JJ; van der Palen J; Ong F; Riemersma S; Struikmans H
Breast Cancer Res Treat; 2015 Sep; 153(2):277-83. PubMed ID: 26268697
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk factors and second primary malignancies among women with breast cancer.
Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
[TBL] [Abstract][Full Text] [Related]
12. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
[TBL] [Abstract][Full Text] [Related]
13. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
[TBL] [Abstract][Full Text] [Related]
14. Second primary in the contralateral breast after treatment of breast cancer.
Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor RK
Radiother Oncol; 2008 Feb; 86(2):171-6. PubMed ID: 17961777
[TBL] [Abstract][Full Text] [Related]
15. Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment.
Rubino C; de Vathaire F; Shamsaldin A; Labbe M; Lê MG
Br J Cancer; 2003 Sep; 89(5):840-6. PubMed ID: 12942115
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer laterality does not influence survival in a large modern cohort: implications for radiation-related cardiac mortality.
Rutter CE; Chagpar AB; Evans SB
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):329-34. PubMed ID: 25304793
[TBL] [Abstract][Full Text] [Related]
17. Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
Goldfarb M; Rosenberg AS; Li Q; Keegan THM
Cancer; 2018 Mar; 124(6):1260-1268. PubMed ID: 29205296
[TBL] [Abstract][Full Text] [Related]
18. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?
Hamilton SN; Tyldesley S; Li D; Olson R; McBride M
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):977-85. PubMed ID: 25832690
[TBL] [Abstract][Full Text] [Related]
19. Hormone receptor-negative breast cancer: undertreatment of patients over 80.
Weiss A; Noorbakhsh A; Tokin C; Chang D; Blair SL
Ann Surg Oncol; 2013 Oct; 20(10):3274-8. PubMed ID: 23838924
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
